Andrew Cheng, President and CEO: Akero Therapeutics AKRO Sell · Filed 25/09/12

Trade details

Type: Insider sale
Amount: $968,349.75
Shares · price: 22,525 sh · $42.99 a share
Held after: 483,173 sh
Stock: Akero Therapeutics AKRO
Person: Andrew ChengPresident and CEO
Trade date: 25/09/10
Filed: 25/09/12
Days to filing: 2 days

Sold 4.5% of holdings

Share of holding sold: 4.5%

Akero Therapeutics trades, last 26 weeks

What else happened in Akero Therapeutics around then

Filed or reported within 30 days of the trade day · 25/08/11~25/10/10

Andrew Cheng's recent trades

Andrew ChengPresident and CEO
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$1.6M
30,000 sh
$1.6M
Filed 25/10/14
Traded 25/10/10
Andrew ChengPresident and CEO
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$321.9K
7,317 sh
$321.9K
Filed 25/09/12
Traded 25/09/10
Andrew ChengPresident and CEO
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$77.3K
1,796 sh
$77.3K
Filed 25/09/12
Traded 25/09/11
Andrew ChengPresident and CEO
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$7,050
158 sh
$7,050
Filed 25/09/12
Traded 25/09/10
Andrew ChengPresident and CEO
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$919K
18,805 sh
$919K
Filed 25/08/13
Traded 25/08/11